Literature DB >> 29938903

Fermented Soybean Suppresses Visceral Fat Accumulation in Mice.

Mamoru Kushida1, Ran Okouchi1, Yui Iwagaki1, Masaki Asano1, Ming Xuan Du1, Kazushi Yamamoto1, Tsuyoshi Tsuduki1.   

Abstract

SCOPE: Mice are fed a soybean diet before or after fermentation in the present work to allow direct comparison of the antiobesity effect of fermentation.
METHODS: C57BL6J mice were fed high-fat diets containing boiled soybeans (prefermentation) or Natto (postfermentation) for 4 weeks. Prefermented cooked soybeans or Natto was added at levels of 2.5 and 5%, which are the amounts that can be ingested in a normal diet once and twice a day. In addition, mice gut microbiota from fecal samples were analyzed to explore the mechanisms of effects caused by fermentation.
RESULTS: Natto intake significantly reduced visceral fat in a dose-dependent manner, inhibited hypertrophy of adipocytes, improved carbohydrate metabolism, and reduced oxidative stress. These effects were seen in mice fed soybeans before fermentation, but were stronger in mice fed Natto. Therefore, soybean intake has beneficial effects and fermentation of soybeans enhances these effects. Natto was found to suppress fatty acid synthesis and promote fatty acid catabolism in the liver. These effects were also stronger with Natto compared with soybeans before fermentation. In addition, Natto had more potent beneficial effects on gut microbiota compared to soybeans.
CONCLUSIONS: These results suggest that Natto intake supports maintenance of health.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Natto; fermented soybeans; gut microbiota; soybeans; visceral fat accumulationzzm321990

Mesh:

Substances:

Year:  2018        PMID: 29938903     DOI: 10.1002/mnfr.201701054

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  7 in total

Review 1.  Traditional Fermented Foods and Beverages from around the World and Their Health Benefits.

Authors:  Leonel Cuamatzin-García; Paola Rodríguez-Rugarcía; Elie Girgis El-Kassis; Georgina Galicia; María de Lourdes Meza-Jiménez; Ma Del Rocío Baños-Lara; Diego Salatiel Zaragoza-Maldonado; Beatriz Pérez-Armendáriz
Journal:  Microorganisms       Date:  2022-06-02

2.  Evaluation of Hypoglycemic and Antioxidant Activities of Soybean Meal Products Fermented by Lactobacillus plantarum FPS 2520 and Bacillus subtilis N1 in Rats Fed with High-Fat Diet.

Authors:  Chung-Hsiung Huang; Chun-Lung Chen; Chen-Che Shieh; Shun-Hsien Chang; Guo-Jane Tsai
Journal:  Metabolites       Date:  2022-05-14

3.  Effect of fermented corn by-products on production performance, blood biochemistry, and egg quality indices of laying hens.

Authors:  Ru Yang; Anam Khalid; Fatima Khalid; Miao Ye; Yang Li; Kai Zhan; Yan Li; Wei Liu; Zaigui Wang
Journal:  J Anim Sci       Date:  2022-05-01       Impact factor: 3.338

Review 4.  Current perspectives on the beneficial effects of soybean isoflavones and their metabolites on plants.

Authors:  Il-Sup Kim
Journal:  Food Sci Biotechnol       Date:  2022-04-05       Impact factor: 3.231

5.  Miso (Fermented Soybean Paste) Suppresses Visceral Fat Accumulation in Mice, Especially in Combination with Exercise.

Authors:  Ran Okouchi; Yuto Sakanoi; Tsuyoshi Tsuduki
Journal:  Nutrients       Date:  2019-03-06       Impact factor: 5.717

6.  Effect of soybean milk fermented with Lactobacillus plantarum HFY01 isolated from yak yogurt on weight loss and lipid reduction in mice with obesity induced by a high-fat diet.

Authors:  Chong Li; Huilin Liu; Jiao Yang; Jianfei Mu; Ranran Wang; Xin Zhao
Journal:  RSC Adv       Date:  2020-09-15       Impact factor: 4.036

7.  Simultaneous Intake of Euglena Gracilis and Vegetables Synergistically Exerts an Anti-Inflammatory Effect and Attenuates Visceral Fat Accumulation by Affecting Gut Microbiota in Mice.

Authors:  Yuto Sakanoi; Shuang E; Kazushi Yamamoto; Toshikuni Ota; Kentarou Seki; Mayumi Imai; Ryuki Ota; Yuta Asayama; Ayaka Nakashima; Kengo Suzuki; Tsuyoshi Tsuduki
Journal:  Nutrients       Date:  2018-10-03       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.